Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Capital Expenditures (2024 - 2025)

Zenas BioPharma has reported Capital Expenditures over the past 2 years, most recently at $18000.0 for Q1 2025.

  • Quarterly results put Capital Expenditures at $18000.0 for Q1 2025, down 18.18% from a year ago — trailing twelve months through Dec 2025 was $18000.0 (down 86.26% YoY), and the annual figure for FY2025 was $18000.0, down 86.26%.
  • Capital Expenditures for Q1 2025 was $18000.0 at Zenas BioPharma, down from $74000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for ZBIO hit a ceiling of $74000.0 in Q4 2024 and a floor of $18000.0 in Q1 2025.